A disease-specific metabolic brain network associated with corticobasal degeneration

Brain

Volumn 137, Issue 11, 2014, Pages 3036-3046

  Niethammer, Martin ^a   Tang, Chris C ^a   Feigin, Andrew ^a   Allen, Patricia J ^a   Heinen, Lisette ^b   Hellwig, Sabine ^c   Amtage, Florian ^c   Hanspal, Era ^d   Vonsattel, Jean Paul ^e   Poston, Kathleen L ^f   Meyer, Philipp T ^c   Leenders, Klaus L ^b   Eidelberg, David ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF FREIBURG   (Germany)

^d ALBANY MEDICAL CENTER   (United States)

^e New York Presbyterian Hospital Columbia University Medical Center   (United States)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain networks; Corticobasal degeneration; Differential diagnosis; FDG PET; Glucose metabolism

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN ASYMMETRY; BRAIN METABOLISM; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HEMISPHERE; HUMAN; INFERIOR FRONTAL GYRUS; INFERIOR PARIETAL LOBULE; LINGUAL GYRUS; MALE; MIDDLE FRONTAL GYRUS; NEUROIMAGING; OCCIPITAL GYRUS; PARIETAL CORTEX; PARKINSONISM; PET SCANNER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; THALAMUS; TOPOGRAPHY; BASAL GANGLIA DISEASES; BRAIN; BRAIN CORTEX; CLASSIFICATION; CLINICAL TRIAL; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE SYSTEM ATROPHY; NERVE CELL NETWORK; NEURODEGENERATIVE DISEASES; PARKINSONIAN DISORDERS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BASAL GANGLIA DISEASES; CEREBRAL CORTEX; CEREBRUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE NET; NEURODEGENERATIVE DISEASES; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84925462153     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu256     Document Type: Article

References (43)

1. Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB. Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 2014; 85: 925-9.
2. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80: 496-503.
3. Boeve BF. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J Mol Neurosci 2011; 45: 350-3.
4. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54 (Suppl 5): S15-9.
5. Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006; 63: 81-6.
6. Burnham KP, Anderson DR. Model selection and multimodel inference. New York: Springer Verlag; 2002.
7. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246 (Suppl 2): II6-15.
8. Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005; 26: 912-21.
9. Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008; 23: 727-33.
10. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 2009; 32: 548-57.
11. Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC, et al. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991; 54: 856-62.
12. Erbetta A, Mandelli ML, Savoiardo M, Grisoli M, Bizzi A, Soliveri P, et al. Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 2009; 30: 1482-7.
13. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351: 2498-508.
14. Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, et al. Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain 2007; 130: 2858-67.
15. Habeck C, Foster N, Perneczky R, Kurz A, Alexopoulos P, Koeppe R, et al. Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage 2008; 40: 1503-15.
16. Habeck C, Stern Y. Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys 2010; 58: 53-67.
17. Hassan A, Whitwell JL, Josephs KA. The corticobasal syndrome-Alzheimer's disease conundrum. Expert Rev Neurother 2011; 11: 1569-78.
18. Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W, et al. [(1)(8)F]FDG-PET is superior to [(1)(2)(3)I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 2012; 79: 1314-22.
19. Hu WT, Rippon GW, Boeve BF, Knopman DS, Petersen RC, Parisi JE, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009; 24: 1375-9.
20. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007; 130: 1834-46.
21. Hughes A, Daniel S, Ben-Shlomo Y, Lees A. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125: 861-70.
22. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41-8.
23. Ling H, O'Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, et al. Does corticobasal degeneration exist? A clinicopathological reevaluation. Brain 2010; 133: 2045-57.
24. Litvan I. Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord 2003; 18 (Suppl 6): S43-50.
25. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48: 119-25.
26. Mahapatra RK, Edwards MJ, Schott JM, Bhatia KP. Corticobasal degeneration. Lancet Neurol 2004; 3: 736-43.
27. Meyer PT, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P, et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med 2011; 52: 393-400.
28. Murray R, Neumann M, Forman MS, Farmer J, Massimo L, Rice A, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 2007; 68: 1274-83.
29. Niethammer M, Eidelberg D. Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol 2012; 72: 635-47.
30. Poston K, Tang C, Eckert T, Dhawan V, Frucht S, Vonsattel J, et al. Network correlates of disease severity in multiple system atrophy. Neurology 2012; 78: 1237-44.
31. Poston KL. Overview of rare movement disorders. Continuum (Minneap Minn) 2010; 16: 49-76.
32. Sha S, Hou C, Viskontas IV, Miller BL. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? Nat Clin Pract Neurol 2006; 2: 658-65.
33. Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, Testa D, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999; 53: 502-7.
34. Spetsieris P, Ma Y, Dhawan V, Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage 2009; 45: 1241-52.
35. Spetsieris P, Ma Y, Dhawan V, Moeller JR, Eidelberg D. Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging. Proc SPIE Med Imaging 2006; 6144: 61445M1-12.
36. Spetsieris P, Ma Y, Peng S, Ko JH, Dhawan V, Tang CC, et al. Identification of disease-related spatial covariance patterns using neuroimaging data. J Vis Exp 2013; 76: e50319.
37. Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage 2011; 54: 2899-914.
38. Tang C, Poston K, Dhawan V, Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 2010a; 30: 1049-56.
39. Tang C, Poston K, Eckert T, Feigin A, Frucht S, Gudesblatt M, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 2010b; 9: 149-58.
40. Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 2010; 25: 2395-404.
41. Tripathi M, Tang C, Peng S, Dhawan V, Sharma R, Jaimini A, et al. Metabolic image-based algorithm for accurate differential diagnosis of parkinsonism: prospective validation in Indian patient population. J Nucl Med 2012; 53 (Suppl 1): 1974.
42. Vlaar AM, van Kroonenburgh MJ, Kessels AG, Weber WE. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol 2007; 7: 27.
43. Zhao P, Zhang B, Gao S. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes. Parkinsonism Relat Disord 2012; 18 (Suppl 1): S60-2.